BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 03, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Abiraterone acetate regulatory update

Johnson & Johnson's Centocor Ortho Biotech Inc. and Janssen-Cilag International N.V. subsidiaries submitted regulatory applications in the U.S. and EU for abiraterone acetate in combination with prednisone to treat metastatic,...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >